TORONTO, May 6 (Reuters) - Biovail Corp, Canada’s biggest publicly traded drugmaker, slashed its dividend 76 percent as it seeks to build up an acquisition war chest, and posted a weaker quarterly profit on Wednesday.
TORONTO, May 6 (Reuters) - Biovail Corp, Canada’s biggest publicly traded drugmaker, slashed its dividend 76 percent as it seeks to build up an acquisition war chest, and posted a weaker quarterly profit on Wednesday.
